CA Patent

CA3280511A1 — Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases and iron supplementation in neurodevelopmental or psychiatric disorder

Assigned to Malian Biologicals GmbH · Expires 2026-03-01 · 0y expired

What this patent protects

Patent listed against Accrufer.

Drugs covered by this patent

Patent Metadata

Patent number
CA3280511A1
Jurisdiction
CA
Classification
—
Expires
2026-03-01
Drug substance claim
No
Drug product claim
No
Assignee
Malian Biologicals GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.